Review article: The genetics of inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 6, 2001, Pages 731-748

  Ahmad, T ^a   Satsangi, J ^b   Mcgovern, D ^a   Bunce, M ^c   Jewell, D P ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR; HLA ANTIGEN; MATRIX METALLOPROTEINASE; MUCIN; SCATTER FACTOR; TREFOIL PEPTIDE; UVOMORULIN;

CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 16; CHROMOSOME 6; CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; ETHNOLOGY; FAMILIAL DISEASE; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVIEW; TWINS; ULCERATIVE COLITIS;

EID: 0034991524     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00981.x     Document Type: Review

References (132)

1. Familial occurrences of ulcerative colitis, regional enteritis and ileocolitis
2. Initial sequencing and analysis of the human genome
3. The sequence of the human genome
4. Proposed classification of patient subgroups in Crohn's disease
5. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
6. Can molecular genetics help in the clinic?
7. Genetic markers may predict disease behaviour in patients with ulcerative colitis
8. Genetic markers in clinically well defined patients with ulcerative colitis (UC)
9. Replication of HLA-DR associations with disease extent and severity in ulcerative colitis
10. A germ line substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis
11. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking
12. Inflammatory bowel disease in a Danish twin register
13. Genetics versus environment in inflammatory bowel disease: Results of a British twin study
14. Concordance rates of twins and siblings in inflammatory bowel disease (IBD)
15. Epidemiology of inflammatory bowel disease
16. Geographic origins of Jewish patients with inflammatory bowel disease
17. Studies of family history among patients with inflammatory bowel disease
18. Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease
19. Epidemiological evidence for a hereditary component in Crohn's disease
20. Familial incidence of Crohn's disease in the Netherlands and a review of the literature
21. Prevalence and incidence of inflammatory bowel disease in family members
22. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis
23. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease
24. Familial aggregation in Crohn's disease: Increased age adjusted risk and concordance in clinical characteristics
25. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease
26. Crohn's disease severity in familial and sporadic cases
27. Severity of disease in familial inflammatory bowel disease
28. Familial empirical risks for inflammatory bowel disease: Differences between Jews and non-Jews
29. Younger age of diagnosis identifies families with greater linkage evidence for IBD Loci on Chromosome 1p, 3q, and 16
30. Chromosome 12 linkage for inflammatory bowel disease is greater in families identified by early age of diagnosis
31. Familial occurrence of inflammatory bowel disease
32. Clinical patterns of familial inflammatory bowel disease
33. Crohn's disease: Concordance for site and clinical type in affected family members - Potential hereditary influences
34. Clinical characteristics of Crohn's disease in 72 families
35. Inflammatory bowel disease: Etiology and pathogenesis
36. Inflammatory Bowel Diseases
37. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
38. Two-stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
39. A genome wide search identifies potential new susceptibility loci for Crohn's disease
40. A second generation linkage map of the human genome
41. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
42. The future of genetic studies of complex human diseases
43. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
44. Single nucleotide polymorphism and linkage disequilibrium within the TCR alpha/delta locus
45. Limits on fine mapping of complex traits
46. Freely associating
47. Association studies of genetic polymorphisms and complex disease
48. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
49. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
50. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1
51. A genome-wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort
52. Genome wide search in Canadian Families with Inflammatory Bowel Disease reveals two novel susceptibility Loci
53. High-density genome scan in Crohn's disease shows confirmed linkage to chromosome 14q11-12
54. Linkage and linkage disequilibrium in chromosome 1p36 in American Chaldeans with inflammatory bowel disease
55. Susceptibility loci in inflammatory bowel disease
56. Susceptibility locus for IBD on chromosome 16 has a role in Crohn's disease but not in ulcerative colitis
57. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12
58. Analysis of Australian Crohn's disease pedigrees refines the localisation for susceptibility to inflammatory bowel disease on chromosome 16
59. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis
60. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to IBD1 locus - A GISC study
61. The International IBD genetics consortium confirms linkage of Crohn's disease to a locus on chromosome 16 (IBD1)
62. Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity
63. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease
64. Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease
65. In vivo analysis of cadherin function in the mouse intestinal epithelium: Essential roles in adhesion, maintenance of differentiation and regulation of programmed cell death
66. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex
67. Mutation screening the CD19 and CD43 (sialophorin genes in Crohn's disease patients
68. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
69. Linkage and association between inflammatory bowel disease and a locus on chromosome 12
70. Fine mapping of regions linked to Crohn's disease on chromosomes 12 and 16
71. Linkage and association between Crohn's disease and a putative locus on chromosome 12
72. Linkage heterogeneity between ulcerative colitis and Crohn's disease at the IBD2 locus
73. Vitamin D receptor gene polymorphism: Association with Crohn's disease susceptibility
74. Analysis of a positional candidate gene for inflammatory bowel disease
75. Analysis of single nucleotide polymorphisms in the NRAMP2 gene, for association with Inflammatory Bowel Disease
76. Identification of multiple candidate genes for IBD susceptibility using high density transcript mapping in the IBD2 locus on chromosome 12q
77. Human leucocyte antigens in Crohn's disease and ulcerative colitis
78. Complete sequence and gene map of a major histocompatability complex
79. Regional enteritis: Evidence for genetic transmission by HLA Typing
80. Regional enteritis and HLA concordance in multiple siblings
81. Discordant HLA haplotype segregation in familial Crohn's disease
82. HLA antigen distribution and HLA haplotype segregation in Crohn's disease
83. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease
84. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses
85. Assessing the role of HLA-linked and unlinked determinants of disease
86. HLA antigens in inflammatory bowel disease
87. HLA antigens in inflammatory bowel disease
88. HLA antigens and clinical manifestations in Crohn's disease
89. Gene and haplotype frequencies of HLA antigens in 269 patients with Crohn's disease
90. HLA antigens in ulcerative colitis
91. HLA antigens in ulcerative colitis and Crohn's disease in Israel
92. HLA antigens in ulcerative colitis: A study in the Sicilian population
93. HLA antigens and ulcerative colitis
94. HLA antigens in inflammatory bowel disease
95. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis
96. HLA-DR and -DQ phenotypes in inflammatory bowel disease: A meta-analysis
97. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time
98. Course and prognostic factors influencing changes in the anatomical extent of ulcerative colitis
99. Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis
100. Genes of the HLA region are important phenotype determining genes in the arthropathies of IBD
101. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease
102. HLA-DRB1*03, but not the TNF?-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
103. Investigation of the association of major histocompatibility complex genes, including HLA class I, class II and Tap genes, with clinical forms of Crohn's disease
104. Enhanced secretion of tumour necrosis factor-alpha, IL-6 and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
105. A short-term study of anti-tumour necrosis factor-alpha chimeric monoclonal antibody (cA2) in Crohn's disease
106. Inflixamab for the treatment of fistulas in patients with Crohn's disease
107. Effects of a tumour necrosis factor-α (TNF-α) promoter base transition on transcriptional activity
108. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
109. Cytokine (TNF, LT, IL-10) polymorphisms in inflammatory bowel disease and normal controls: Differential effects on production and allele frequencies
110. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)
111. Cytokine gene polymorphisms in inflammatory bowel disease
112. Crohn's disease is associated with novel polymorphisms in the 5′ flanking region of the tumour necrosis gene
113. Polymorphism at position-1031 in the TNF gene confers susceptibility to Crohn's disease
114. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6
115. Response to anti-TNFa treatment is associated with the TNFa-308*1 allele
116. TNF microsatellite polymorphism does not predict response to infliximab in patients with Crohn's disease
117. Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T cells
118. MICA, a new polymorphic HLA related antigen, is expressed mainly by keratinocytes, endothelial cells and monocytes
119. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
120. Novel association of triplet repeat polymorphism in mica gene on chromosome 6 with ulcerative colitis
121. A novel polymorphism in class 1 major histocompatability complex chain related gene A is associated with Crohn's disease
122. MHC Class I like gene-A (MICA) is associated with ulcerative colitis but not Crohn's disease
123. Association of the peripheral arthropathies of inflammatory bowel disease and oral ulceration with the MHC class I chain like molecule (MICA)
124. Replication of linkage on 14q11-12 in inflammatory bowel disease
125. Fine mapping of the chromosome 3P susceptibility locus in inflammatory bowel disease
126. Linkage of inflammatory bowel disease to human chromosome 6p
127. Precision mapping of chromosome 12 linkage in IBD. Evidence for a haplotype association
128. High density mapping of pericentromeric chromosome 12 in inflammatory bowel disease
129. Analysis of association at single nucleotide polymorphisms in the APOE region
130. Searching for genetic determinants in the new millennium
131. Genetic studies in children and young adults: A population study